Connecting for innovation and impact for all in global health

contact us
Membership
Subscribe

Search

Events
MEMBERS
Show Members
TOPICS
REGIONS
Outcomes-Based Financing: A Novel Tool in the Fight Against AMR | PATH and Partners Share New Research and Model to Drive Responsible Antibiotic Use

Outcomes-Based Financing: A Novel Tool in the Fight Against AMR | PATH and Partners Share New Research and Model to Drive Responsible Antibiotic Use

At a recent Clinton Global Initiative (CGI) Deeper Dive Session,  PATH — together with Pfizer, the Bay Area Global Health Alliance, and Social Finance International — shared early-phase research findings aimed at understanding the drivers of antibiotic misuse and presented an innovative financing design approach to incentivize the correct use of antibiotics. The session aimed to raise awareness and engage potential partners around a next-phase pilot to test outcomes-based financing (OBF) as a new tool to drive more sustainable and effective stewardship.

Tackling AMR with Outcomes-Based Financing: Findings from Tanzania and Senegal

Tackling AMR with Outcomes-Based Financing: Findings from Tanzania and Senegal

On February 25, Neha Agarwal, senior director of strategy at PATH and Alliance board vice chair, led a session for Stanford Mussallem Center for Biodesign’s Innovation and Health Equity Series. She discussed how outcomes-based financing (OBF) can be leveraged to tackle antimicrobial resistance (AMR). Her talk, which provided a first look at data from a year-long study in Tanzania and Senegal, emphasized how innovative financing mechanisms could reshape global health strategies.

PATH, Pfizer, and the Bay Area Global Health Alliance Partner to Combat Antimicrobial Resistance in Senegal and Tanzania Using an Outcomes-Based Financing Mechanism

PATH, Pfizer, and the Bay Area Global Health Alliance Partner to Combat Antimicrobial Resistance in Senegal and Tanzania Using an Outcomes-Based Financing Mechanism

During the Clinton Global Initiative (CGI) 2024 Annual Meeting, PATH, in partnership with the Bay Area Global Health Alliance and Pfizer, announced a Commitment to Action: Outcomes-Based Financing as a Tool to Curb AMR in LMICs. This commitment aims to combat antimicrobial resistance (AMR) and incentivize antimicrobial stewardship (AMS) through an innovative outcomes-based financing mechanism.

UNGA79

UNGA79

The 79th session of the UN General Assembly (UNGA 79) will open on Tuesday, 10 September 2024. The first day of the high-level General Debate will be Tuesday, 24 September 2024. When global leaders meet at the UN, they will confront yet another year of complex crises and conflicts — as a deeply divided world watches. The UN is the only place on Earth where countries — whether big or small — have a say. The debates and conversations that will unfold during UNGA 79 will shape the solutions that can redefine our future. UNGA 79 will also include High-level Meetings on two issues of existential importance: Antimicrobial resistance (AMR) and the global threat of sea-level rise.